Glen Eagle Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $383K | Buy |
|
|||||
|
2025
Q2 | $389K | Sell |
|
|||||
|
2025
Q1 | $622K | Buy |
|
|||||
|
2024
Q4 | $194K | Sell |
|
|||||
|
2024
Q3 | $179K | Hold |
|
|||||
|
2024
Q2 | $144K | Sell |
|
|||||
|
2024
Q1 | $217K | Sell |
|
|||||
|
2023
Q4 | $208K | Sell |
|
|||||
|
2023
Q3 | $236K | Buy |
|
|||||
|
2023
Q2 | $218K | Sell |
|
|||||
|
2023
Q1 | $265K | Sell |
|
|||||
|
2022
Q4 | $280K | Sell |
|
|||||
|
2022
Q3 | $279K | Sell |
|
|||||
|
2022
Q2 | $353K | Buy |
|
|||||
|
2022
Q1 | $287K | Buy |
|
|||||
|
2021
Q4 | $178K | Sell |
|
|||||
|
2021
Q3 | $263K | Hold |
|
|||||
|
2021
Q2 | $297K | Buy |
|
|||||
|
2021
Q1 | $274K | Buy |
|
|||||
|
2020
Q4 | $251K | Sell |
|
|||||
|
2020
Q3 | $246K | Buy |
|
|||||
|
2020
Q2 | $235K | Buy |
|
|||||
|
2020
Q1 | $216K | Buy |
|
|||||
|
2019
Q4 | $238K | Buy |
|
|||||
|
2019
Q3 | $158K | Buy |
|
|||||
|
2019
Q2 | $137K | Sell |
|
|||||
|
2019
Q1 | $186K | Sell |
|
|||||
|
2018
Q4 | $205K | Buy |
|
|||||
|
2018
Q3 | $244K | Buy |
|
|||||
|
2018
Q2 | $218K | Sell |
|
|||||
|
2018
Q1 | $253K | Sell |
|
|||||
|
2017
Q4 | $254K | Buy |
|
|||||
|
2017
Q3 | $249K | Buy |
|
|||||
|
2017
Q2 | $176K | Sell |
|
|||||
|
2017
Q1 | $175K | Sell |
|
|||||
|
2016
Q4 | $220K | Buy |
|